These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16117429)

  • 21. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic aims for atrial fibrillation in patients with heart failure].
    Lewalter T; Nitschmann S
    Internist (Berl); 2009 Jan; 50(1):101-3. PubMed ID: 19137270
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of converting angiotensin inhibitors in children. II. Personal experience with enalapril].
    Rokicki W; Borowicka E
    Wiad Lek; 1997; 50(4-6):85-93. PubMed ID: 9381720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Why heart failure clinics?].
    Hülsmann M; Pacher R
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):819-21. PubMed ID: 12503472
    [No Abstract]   [Full Text] [Related]  

  • 26. [Differential indications for heart medications].
    Assmann I; Modersohn D
    Z Arztl Fortbild (Jena); 1991 Jun; 85(12):593-5. PubMed ID: 1926930
    [No Abstract]   [Full Text] [Related]  

  • 27. Congestive heart failure and disorders of the heart beat.
    Weaver T; Eisold JF
    Dent Clin North Am; 1996 Jul; 40(3):543-61. PubMed ID: 8829045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of optimal medical therapy on the arrhythmias and heart rate variability detected with 24 hour Holter in a series of patients from a heart failure clinic].
    Cárdenas E; Asensio E; Orea A; Castillo L; Narváez R; Dorantes J; Rebollar V; Hernández P; Nájera E; Oseguera J
    Rev Invest Clin; 2004; 56(5):609-14. PubMed ID: 15776865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?
    Nattel S
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):332-3. PubMed ID: 16265553
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent aspects of cardiologic therapy in advanced age].
    Diederich KW; Potratz J; Stierle U
    Z Gerontol; 1987; 20(1):3-7. PubMed ID: 3577314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of cardiac insufficiency in patients with chronic obstructive lung disease].
    Krushka SI; Butorov IV; Butorov SI; Bodrug NI
    Klin Med (Mosk); 2008; 86(10):28-31. PubMed ID: 19069455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
    Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
    Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications and contraindications for therapy with cardiac glycosides].
    Haasis R
    Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Consensus conference "Therapy of chronic heart insufficiency" inaugurated by the Munich Collegium for Therapy Research e.V. together with the German Society for Cardiovascular Research].
    Burkart F; Erdmann E; Hanrath P; Kübler W; Mutschler E; Riegger G; Riecker G; Scholz H; Schultheiss HP
    Z Kardiol; 1993 Mar; 82(3):200-10. PubMed ID: 8475658
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of treatment with trimethazidine on characteristics of arrhythmia and indicators of heart rhythm in patients with chronic cardiac failure].
    Nesterova IV; Kutuzova AE; Sveshnikov IuG; Sitnikova MIu; Nedoshivin AO
    Ter Arkh; 2003; 75(3):61-4. PubMed ID: 12718225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The therapy of chronic heart failure].
    Trenckmann H
    Z Gesamte Inn Med; 1990 Jun; 45(12):342-7. PubMed ID: 2201131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
    Brugts JJ; Ninomiya T; Boersma E; Remme WJ; Bertrand M; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML
    Eur Heart J; 2009 Jun; 30(11):1385-94. PubMed ID: 19346520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.